Depomed is a specialty pharmaceutical company that formulates its products and product candidates with its proprietary Acuform drug delivery technology – designed to improve existing oral medications, allowing for extended release of medications to the upper gastrointestinal tract when dosed with food. The company currently has three approved and marketed products: Gralise, a treatment for postherpetic neuralgia; Zipsor, an NSAID indicated for mild to moderate acute pain relief in adults; and Glumetza for adults with type 2 diabetes. For more information, visit the company’s Web site: http://www.depomed.com
Let us hear your thoughts below:
